These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31274014)

  • 21. Use of functional respiratory imaging to characterize the effect of inhalation profile and particle size on lung deposition of inhaled corticosteroid/long-acting β2-agonists delivered via a pressurized metered-dose inhaler.
    Van Holsbeke C; De Backer J; Vos W; Marshall J
    Ther Adv Respir Dis; 2018; 12():1753466618760948. PubMed ID: 29499614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Formulation Variables on Lung Dosimetry of Albuterol Sulfate Suspension and Beclomethasone Dipropionate Solution Metered Dose Inhalers.
    Schroeter JD; Sheth P; Hickey AJ; Asgharian B; Price OT; Holt JT; Conti DS; Saluja B
    AAPS PharmSciTech; 2018 Jul; 19(5):2335-2345. PubMed ID: 29858973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of suspension-based metered dose inhaler formulations composed of spray-dried budesonide microcrystals dispersed in HFA-134a.
    Tarara TE; Hartman MS; Gill H; Kennedy AA; Weers JG
    Pharm Res; 2004 Sep; 21(9):1607-14. PubMed ID: 15497686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and performance of a new hydrofluoroalkane (HFA 134a)-based metered dose inhaler (MDI) of salmeterol.
    Peyron ID; Britto IL; Benissan LB; Tardieu BZ
    Respir Med; 2005 Apr; 99 Suppl A():S20-30. PubMed ID: 15777605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid systemic delivery of zolmitriptan using an adhesive dermally applied microarray.
    Kellerman DJ; Ameri M; Tepper SJ
    Pain Manag; 2017 Nov; 7(6):559-567. PubMed ID: 28741429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relative bioavailability of budesonide/glycopyrrolate/formoterol fumarate triple therapy delivered using next generation propellants with low global warming potential.
    Aurivillius M; Bednarczyk A; Kokot M; Madriaga J; Mei J; Collison K; Surujbally R; Archbell J; Joshi V; Gillen M
    Pulm Pharmacol Ther; 2023 Dec; 83():102245. PubMed ID: 37607661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formulation of zolmitriptan sublingual tablets prepared by direct compression with different polymers: in vitro and in vivo evaluation.
    Bayrak Z; Tas C; Tasdemir U; Erol H; Ozkan CK; Savaser A; Ozkan Y
    Eur J Pharm Biopharm; 2011 Aug; 78(3):499-505. PubMed ID: 21352916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of zolmitriptan transfersomes by Box-Behnken design for nasal delivery: in vitro and in vivo evaluation.
    Pitta SK; Dudhipala N; Narala A; Veerabrahma K
    Drug Dev Ind Pharm; 2018 Mar; 44(3):484-492. PubMed ID: 29124986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain targeting efficiency of antimigrain drug loaded mucoadhesive intranasal nanoemulsion.
    Abdou EM; Kandil SM; Miniawy HMFE
    Int J Pharm; 2017 Aug; 529(1-2):667-677. PubMed ID: 28729175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine.
    Tuchman M; Hee A; Emeribe U; Silberstein S
    CNS Drugs; 2006; 20(12):1019-26. PubMed ID: 17140280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors affecting the stability and performance of ipratropium bromide; fenoterol hydrobromide pressurized-metered dose inhalers.
    Ninbovorl J; Sawatdee S; Srichana T
    AAPS PharmSciTech; 2013 Dec; 14(4):1294-302. PubMed ID: 23975571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Part II: clinical efficacy and tolerability of zolmitriptan orally disintegrating tablet in the acute treatment of migraine.
    Loder EW; Dowson AJ; Spierings EL
    Curr Med Res Opin; 2005; 21 Suppl 3():S8-12. PubMed ID: 16083518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of ADAM Zolmitriptan for the Acute Treatment of Difficult-to-Treat Migraine Headaches.
    Tepper SJ; Dodick DW; Schmidt PC; Kellerman DJ
    Headache; 2019 Apr; 59(4):509-517. PubMed ID: 30698272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fast relief from migraine attacks using fast-disintegrating sublingual zolmitriptan tablets.
    Mahmoud AA; Salah S
    Drug Dev Ind Pharm; 2012 Jun; 38(6):762-9. PubMed ID: 22023340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet.
    Charlesworth BR; Dowson AJ; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
    CNS Drugs; 2003; 17(9):653-67. PubMed ID: 12828501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute safety of the CFC-free propellant HFA-134a from a pressurized metered dose inhaler.
    Donnell D; Harrison LI; Ward S; Klinger NM; Ekholm BP; Cooper KM; Porietis I; McEwen J
    Eur J Clin Pharmacol; 1995; 48(6):473-7. PubMed ID: 8582466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zolmitriptan oral tablet in migraine treatment: high placebo responses in adolescents.
    Rothner AD; Wasiewski W; Winner P; Lewis D; Stankowski J
    Headache; 2006 Jan; 46(1):101-9. PubMed ID: 16412157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intranasal zolmitriptan for the treatment of acute migraine.
    Tepper SJ; Chen S; Reidenbach F; Rapoport AM
    Headache; 2013 Sep; 53 Suppl 2():62-71. PubMed ID: 24024604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computational analyses of a pressurized metered dose inhaler and a new drug-aerosol targeting methodology.
    Kleinstreuer C; Shi H; Zhang Z
    J Aerosol Med; 2007; 20(3):294-309. PubMed ID: 17894536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population Pharmacokinetic Analysis of Zolmitriptan and Its Metabolite in Adults and Adolescents to Support Dose Selection in Children With Migraine.
    Zhou W; Li J; Birmingham B; Xu H; Lillieborg S; Zhou D; Al-Huniti N
    J Clin Pharmacol; 2017 Oct; 57(10):1258-1267. PubMed ID: 28581633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.